speb/financial-data huggingface dataset:
XOM.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 3951000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 3951000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 32804000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 36755000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 899000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1150000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 34010000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 34010000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 6901000000.00
XOM.TO income_statement (annual, 2024-12-31) — Minority Interests: -1383000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 754000000.00
XOM.TO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -19629000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Net Debt: 14730000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Income: 33680000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 33680000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 35063000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 33680000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 33680000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 35063000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 35063000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Interest Income: -996000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -3299000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -5012000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -251000000.00
XOM.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -996000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1444000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 6913000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Net PPE: 294318000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -24306000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -4761000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 263705000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 5763000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 5763000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 39042000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 39042000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 9700000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 7084000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 7084000000.00
XOM.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 73311000000.00
XOM.TO income_statement (annual, 2024-12-31) — Normalized Income: 33680000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 55022000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -358000000.00
XOM.TO income_statement (annual, 2024-12-31) — Operating Income: 39652000000.00
XOM.TO income_statement (annual, 2024-12-31) — Operating Revenue: 339247000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4353094536.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 1598000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 4892000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 4892000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -14619000000.00
XOM.TO income_statement (annual, 2024-12-31) — Other Gand A: 9976000000.00
XOM.TO income_statement (quarterly, 2024-12-31) — Other Gand A: 2617000000.00
XOM.TO income_statement (annual, 2024-12-31) — Other Income Expense: 10217000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1087000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 19967000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 25719000000.00
XOM.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 4023000000.00
XOM.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 826000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Payable: 11197000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 11197000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Properties: 23823000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 23823000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 8399000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 8399000000.00
XOM.TO income_statement (annual, 2024-12-31) — Other Taxes: 26288000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Payables: 65352000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 65352000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -358000000.00
XOM.TO income_statement (annual, 2024-12-31) — Pretax Income: 48873000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -1712000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -3299000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -24306000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 4080000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 4080000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Receivables: 43681000000.00
XOM.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 262505000000.00
XOM.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 23442000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -5911000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -19629000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Restricted Cash: 158000000.00
XOM.TO balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 158000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 470903000000.00
XOM.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 754000000.00
XOM.TO cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
XOM.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 9976000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Share Issued: 8019094536.00
XOM.TO cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
XOM.TO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -4761000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 263705000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 263705000000.00
XOM.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
XOM.TO income_statement (annual, 2024-12-31) — Tax Provision: 13810000000.00
XOM.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.33
XOM.TO balance_sheet (annual, 2024-12-31) — Total Assets: 453475000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 296509000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Debt: 41710000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 270606000000.00
XOM.TO income_statement (annual, 2024-12-31) — Total Expenses: 299595000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 182869000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 361485000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 112562000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 7632000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
XOM.TO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 3666000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 238817000000.00
XOM.TO balance_sheet (annual, 2024-12-31) — Working Capital: 21683000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 8639000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 81058000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 63987000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 46303000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 32004695874.00
XOM.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.24
XOM.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 23187000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5898000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 46426000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 17036000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 17036000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -4335000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -13579000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -4135000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 12953000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -878000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -4761000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 46426000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -4335000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 262720000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -4804000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 62573000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 91233000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 4728000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4728000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 73829000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5702000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 32004695874.00
XOM.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.24
XOM.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 7713000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Non Current: 1381000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — EBIT: 11805000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — EBITDA: 17507000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 1369000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 86000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 10015000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 18512000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -13579000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 20502000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 7055000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -14338000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2540000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 18485000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 2596000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 5114000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 205000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 205000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 537000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 24478000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 300271000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4135000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 47853000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 280000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 32823000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 32823000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 280000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -7000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 7086000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -320000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -4804000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 20515000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Income: 7713000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 7713000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 8033000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7713000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7713000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 8033000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 8033000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -205000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -153000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -4309000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 273000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -205000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -131000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1916000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 292646000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5898000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -4582000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 262720000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 39091000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 39091000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 10015000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 17507000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 7713000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 12953000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Operating Income: 9846000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 81058000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4309638821.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1940000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -14338000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 2540000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 1959000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 96000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 20176000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 24963000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 590000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 64000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Other Taxes: 6035000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Payables: 69101000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 69101000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 11600000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -153000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5898000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 3976000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 46303000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 62573000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5702000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4589000000.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -4804000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1476000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 474290000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2540000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 8018638821.00
XOM.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -4582000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 262720000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 262720000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
XOM.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 3567000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.31
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 451908000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 295543000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 37551000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 269806000000.00
XOM.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 71212000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 182102000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 360675000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 108273000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 5114000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 3709000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 243658000000.00
XOM.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 17404000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 9036000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 79477000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 59725000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 41792000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 31536617848.00
XOM.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.22
XOM.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 18512000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6283000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 46629000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 14352000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 14352000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -4288000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -8685000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -6180000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 11550000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -3970000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3315000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 46629000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -4288000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 262593000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -4964000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 61530000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 85108000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 5419000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5419000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 68161000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6101000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 31629419757.00
XOM.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.22
XOM.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7082000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Non Current: 1113000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — EBIT: 10850000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — EBITDA: 16951000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 1462000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 514000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 10352000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 15711000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -8685000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 21364000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 5267000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -12436000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 17947000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2986000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 3017000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 145000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 145000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 339000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 25371000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 301582000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -6180000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 46092000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1032000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 33570000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 33570000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 603000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -6000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 7369000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -272000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -4964000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 24637000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Income: 7082000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7082000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7354000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7082000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7082000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 7354000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7354000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -145000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -319000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 932000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 597000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -145000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -365000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 422000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 295356000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6283000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 335000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 262593000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 39368000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 39368000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 10352000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 16951000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 7082000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 11550000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Operating Income: 8911000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 79477000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4263247021.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2234000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -12436000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 1939000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2065000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 21041000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 25071000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 477000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 251000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Other Taxes: 6257000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Payables: 62742000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 62742000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 10705000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -319000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -6283000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 4007000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 41792000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 61530000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6101000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -100000000.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -4964000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1359000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 477061000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2528000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 8019247021.00
XOM.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -94000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 262593000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 262593000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
XOM.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 3351000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.34
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 447597000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 296163000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 38989000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 269962000000.00
XOM.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 70566000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 177635000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 362489000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 109474000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 3017000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 3756000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 248661000000.00
XOM.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 16947000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 9656000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 83331000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 65382000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 45285000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 31320036881.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 15711000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -8727000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 46808000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 13814000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 13814000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -4242000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -8083000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -8479000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 14788000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -152000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1774000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 46808000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -4242000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 260561000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -5126000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 64497000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 88505000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 9212000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 9212000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 77850000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6475000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 31320036881.00
XOM.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 7548000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Non Current: 1145000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — EBIT: 11022000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — EBITDA: 17497000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 1267000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -68000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 10394000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 13869000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -8083000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 23174000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 6061000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -12782000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 18834000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 2266000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 3256000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 90000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 90000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 597000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 27238000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 302597000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -8479000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 46138000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1803000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 32824000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 32824000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 262000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 7662000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -220000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -5126000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 28222000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Income: 7548000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 7548000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 7768000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 7548000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 7548000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 7768000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 7768000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -90000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -501000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 1664000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 262000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -90000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -379000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 749000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 298388000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -8727000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 1402000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 260561000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 39942000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 39942000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 10394000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 17497000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 7548000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 14788000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Operating Income: 9178000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 83331000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4217165614.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2113000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -12782000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 1844000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 697000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 21309000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 23962000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 577000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 149000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Other Taxes: 6475000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Payables: 68638000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 68638000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 10932000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -501000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -8727000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 4064000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 45285000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 64497000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6475000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -139000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -5126000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 55000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 480367000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
XOM.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3032000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 8019165614.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 1541000000.00
XOM.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -139000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 260561000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 260561000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
XOM.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 3164000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.32
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 454340000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 293385000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 42036000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 268223000000.00
XOM.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 74153000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 186117000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 365835000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 108267000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 3256000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 0.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 3802000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 253832000000.00
XOM.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 10655000000.00
XOM.TO income_statement (annual, 2025-12-31) — +Operating Expense: 37302000000.00
XOM.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 9971000000.00
XOM.TO income_statement (annual, 2025-12-31) — +Total Revenue: 323905000000.00
XOM.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 80039000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 36049000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 36049000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 35744000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 35744000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -270686000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -270686000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -270000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -270000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 271000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 271000000.00
XOM.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 31440085998.00
XOM.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 31030714554.00
XOM.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.92
XOM.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.21
XOM.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 23187000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 13869000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -28358000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -7450000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6313000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6313000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 46150000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 46150000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 10681000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 10681000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10681000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10681000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -17231000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -4366000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -39081000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8734000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -25927000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7133000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 51970000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 12679000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -4300000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -164000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Change In Payable: -222000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -222000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -3042000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -7728000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2728000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -13038000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3188000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Commercial Paper: 3059000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Commercial Paper: 3059000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Common Stock: 46150000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 46150000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -17231000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -4366000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 259386000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 259386000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -20273000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -5379000000.00
XOM.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 252665000000.00
XOM.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 64065000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Current Assets: 83382000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 83382000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Current Debt: 9296000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 9296000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 9296000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 9296000000.00
XOM.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 72330000000.00
XOM.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 72330000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 765000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 765000000.00
XOM.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 25993000000.00
XOM.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7715000000.00
XOM.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 31440085998.00
XOM.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 31030714554.00
XOM.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.92